---
title: "Artelo Biosciences, Inc. (ARTL.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/ARTL.US.md"
symbol: "ARTL.US"
name: "Artelo Biosciences, Inc."
industry: "制药"
---

# Artelo Biosciences, Inc. (ARTL.US)

| Item | Detail |
|------|--------|
| Industry | 制药 |
| Location | 美股市场 |
| Website | [artelobio.com](https://artelobio.com) |

## Company Profile

Artelo Biosciences, Inc.是一家临床阶段的生物制药公司，专注于开发和商业化针对脂质信号通路的治疗药物。该公司的产品候选管线包括 ART27.13，一种合成的双重大麻素 G 蛋白偶联受体激动剂，目前正在进行针对癌症相关厌食症的 1b/2a 期临床试验；以及 ART12.11，一种由大麻二酚和四甲基吡嗪组成的共晶，用于治疗焦虑、抑郁、创伤后应激障碍（PTSD）、癫痫和失眠等其他潜在适应症。它还提供 ART26.12，一种脂肪酸结合蛋白 5 抑制剂，用于治疗化疗引起的周围神经病、糖尿病神经病、前列腺癌和乳腺癌、疼痛、皮肤病和焦虑障碍。该公司之前被称为 Reactive Medi...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.20 | 70/257 | - | - | - |
| PB | -1.99 | 207/257 | 10.41 | 4.81 | 1.12 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-11-19T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 0 | 0% |
| Hold | 1 | 100% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.19 |

## References

- [Company Overview](https://longbridge.com/en/quote/ARTL.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/ARTL.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/ARTL.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.